Company Description
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey.
It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events.
The company was founded in 2006 and is based in Waltham, Massachusetts.
| Country | United States |
| Founded | 2006 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 136 |
| CEO | William Febbo |
Contact Details
Address: 260 Charles Street, Suite 302 Waltham, Massachusetts 02453 United States | |
| Phone | 248-651-6568 |
| Website | optimizerx.com |
Stock Details
| Ticker Symbol | OPRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001448431 |
| CUSIP Number | 68401U204 |
| ISIN Number | US68401U2042 |
| Employer ID | 26-1265381 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| William J. Febbo | Chief Executive Officer and Director |
| Stephen L. Silvestro | President |
| Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer and Chief Operating Officer |
| Andrew Jacob D'Silva | Senior Vice President of Corporate Finance |
| Marion K Odence-Ford | General Counsel and Chief Compliance Officer |
| Maira Alejandra | Media Relations Manager |
| Sheryl Kearney | Human Resources Manager |
| Terence J. Hamilton | Senior Vice President of Pharma |
| Dr. Doug Besch | Chief Product Officer |
| Theresa Greco | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Aug 15, 2024 | 10-Q | Quarterly Report |
| Aug 15, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 8, 2024 | 8-K | Current Report |
| Jul 23, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jun 18, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |